Innovation developments

There were a lot of exciting innovation developments happening in health IT this week from smart contact lenses to work on new development hubs.

The U.S. patent office granted Google a patent for its smart contact lens featuring a chip, electric circuit and sensor technology.

The search giant has previously said it is partnering with the pharmaceutical company Novartis to create a smart contact lens that could monitor blood sugar for people with diabetes. Google has been testing various prototypes of smart contact lens and is currently in talks with the FDA about a lens that measures glucose levels in users’ tears, according to an article in TIME. The company says the chip and sensor are embedded between two layers of contact lens material and a tiny pinhole lets tear fluid from the eye reach the glucose sensor, which can measure levels every second.

New York City is set to ramp up its life sciences position through a $150 million public-private partnership and increasing research and development space by 150 percent.

The Early-Stage Life Sciences Funding Initiative will identify and invest in the most promising research generated by the city’s academic medical institutions and leading entrepreneurs.

Meanwhile, New Orleans-based Ochsner Health System has launched innovationOchsner, or iO, that will support companies working to revolutionize care. The organization also announced a three-year innovation challenge in collaboration with GE Healthcare.

iO will encourage new thinking around the best ways to enable patients to collect their health data and impact their care, according to a release. It will partner with other leading innovators both inside and outside of the healthcare industry to identify promising solutions and provide resources and support to develop concepts. iO will potentially provide an environment in which innovation for both patients and providers can be tested, and also may fund the future development and launch of successful ideas to the point that they are available to other patients and healthcare providers worldwide.

Also, this week the Patient-Centered Outcomes Research Institute announced $5 million in funding for a demonstration project of its national clinical research data network.

PCORI, a not-for-profit organization created under the Affordable Care Act to fund comparative-effectiveness research, approved an initial $93.5 million funding round in December 2013 to build the data network--PCORnet.

Initial funding went to 18 research networks focused on patients with specific health conditions who are interested in sharing health data; and 11 clinical data research networks with healthcare systems collecting data during care delivery.

Exciting times.

Beth Walsh

Clinical Innovation + Technology editor

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.